Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)

NCT05638620 is registered in ClinicalTrials.gov with Jonathann Kuo, MD as lead sponsor.

NCT NCT05638620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05638620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)
Lead sponsor
Jonathann Kuo, MD
Phase
Phase 1
Overall status
Completed
Start date
January 3, 2023
Completion date
December 30, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 recurrent, dysautonomia, dysautonomia like disorder, dysautonomia orthostatic hypotension syndrome, long covid, long covid19, post acute covid-19 syndrome, post acute sequelae of covid-19, post covid-19 condition, post covid-19 condition, unspecified, post-acute covid-19, post-acute covid-19 infection, post-covid syndrome, post-covid-19 syndrome, sars-cov2 infection